Wed, Apr 23, 2025 | Updated 10:49 IST
Dr Reddy's launches Avigan (Favipiravir) for COVID-19 treatment
Aug 19, 2020
Hyderabad (Telangana) [India], Aug 19 : Dr Reddy's Laboratories on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets in India for treatment...
US SEC sues Elon Musk over delayed disclosure of Twitter's ownership stake
Jan 15, 2025
In the lawsuit, the SEC alleged, "Had Musk and his wealth manager disclosed his ownership as required, the stock price would likely have increased...
Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid-19 vaccine
Jul 01, 2021
New Delhi [India], July 1 : The central government's Subject Expert Committee (SEC) has denied permission to Dr Reddy's Laboratories for conducting Phase 3...
Bourses closed on account of Ambedkar Jayanti
Apr 14, 2021
Mumbai (Maharashtra) [India], April 14 : The National Stock Exchange (NSE) of India and BSE Ltd (earlier known as Bombay Stock Exchange) were closed...
IFFCO reduces price of NP fertilisers with immediate effect on all stock
Nov 11, 2020
New Delhi [India], November 11 : IFFCO on Wednesday announced a reduction of Rs 50 per bag in the price of NP fertilisers across...
IdeaForge Technology makes stellar market debut with 94 pc listing gains
Jul 07, 2023
It listed on the stock markets at Rs 1,305 against its issue price of about Rs 672, thus accumulating 94 per cent listing gains...
Ind-Ra assigns A1-plus rating to Dr Reddy's commercial papers
May 02, 2020
Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharmaceutical Services Ltd
Jan 21, 2022
Dr Reddy's Lab gets emergency use authorisation for Sputnik V in India
Apr 13, 2021
Dr Reddy's joins Science Based Targets initiative (SBTi), sets 2030 GHG emission targets
Oct 05, 2020
Tega Industries makes market debut at 68 pc premium
Dec 13, 2021
MedPlus makes market debut at 30 per cent premium
Dec 23, 2021
Related Videos
No Result Found